1. Home
  2. Research
  3. Research Groups
  4. Drug utilisation and health outcomes of pharmacotherapy

Drug utilisation and health outcomes of pharmacotherapy

We are a transversal group, we have a wide knowledge and training in relation to pharmacotherapy with a high complexity and specialization. We are experts in the safe and effective use of medicines, applying efficiency and innovation criteria. On the other hand, being a central service, we have experience in process management.

Our clinical areas with greater presence of pharmacists are: elderly patient (geriatrics), infectious (HIV, HCV, HBV, HBV, PROA), hematology, rheumatology, dermatology, neurology and emergency. We offer:

  • Pharmacovigilance, medication safety experience.
  • Knowledge and availability of medications.
  • Data on the use and consumption of medicines.
  • Preparation of drug preparations.
  • Clean rooms.
  • Drug-related technologies.
  • Structure for the management and development of Clinical Trials.
  • Quality Management System Certification.

Search for publications

Only original articles, editorials, guidelines.

  • Velez-Diaz-Pallares, M, Esteban-Cartelle, B, Gramage-Caro, T, Montero-Llorente, B, Parro-Martin, MD, Rodriguez-Sagrado, MA, Alvarez-Diaz, AM.

    Disorders in sleep quality associated with integrase inhibitors in the treatment of HIV

    Revista Espanola de Salud Publica . 97: . Number of citations: 1

  • Rosas Cancio-Suárez M, Alonso C, Vivancos MJ, Pérez-Elías MJ, Cárdenas MJ, Vélez-Díaz-Pallarés M, Corbacho MD, Martín-Pedraza L, Muriel A, Martínez-Sanz J, Moreno S.

    Impact of COVID-19 on the Care of Patients with HIV Infection.

    Journal of Clinical Medicine . 12(12): . Number of citations: 5

    [doi:10.3390/jcm12123882]

  • Quesada Muñoz L, Fernández-Fradejas J, Martinez-Barros H, Sánchez Cuervo M, Martín Rufo M, Pintor Recuenco MDR, Quereda Rodríguez-Navarro C, Álvarez-Díaz AM, Saez de la Fuente J.

    Real-world effectiveness and factors associated with increased mortality in non-critically ill patients with COVID-19 pneumonia receiving remdesivir

    European Journal of Hospital Pharmacy . 31(6): 532-536. Number of citations: 1

    [doi:10.1136/ejhpharm-2023-003729]

  • Alfonsín Lara M, Áreas Del Águila V, Contreras Macías E, Mancebo González A, Martínez Castro B, Pérez Menéndez-Conde C, Sanmartín Fenollera P, Morillo-Verdugo R.

    Knowledge, perception and predisposition to implement the MAPEX strategy in hospital pharmacy residents in Spain. FIRMAPEX project.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2025.04.007]

  • Martínez-Barros H, Muñoz-García M, Antolín-Amérigo D, Sánchez-Cuéllar S, Morales-Tirado A, de-Andrés-Martín A, De-Los-Santos-Granados G, Yeguas-Ramírez L, Blitz-Castro E, Santamaría-Gadea A, de-la-Hoz-Caballer B, Martín-Aragón S, González-de-Olano D, Álvarez-Díaz AM.

    Designing a patient onboarding in a multidisciplinary severe asthma unit.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2025.07.003]

  • Valdeolmillos Carbó LV, Esteban Gómez MJ, Ruiz-Jarabo Gómez I, Ribed Sánchez A, Vicente Oliveros N, Guisado Gil AB, Campino Villegas A, Campillos P, Olier Martínez P, de Pourcq JT.

    Guidelines on the perioperative management of chronic medication in surgical patients.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2025.07.002]

  • Vélez-Díaz-Pallarés M, Parro-Martín MÁ, Martínez-Barros H, Montero-Llorente B, Menacho-Román M, Gómez-Lozano A, Royo RN, Carro LM, Álvarez-Díaz A.

    Biochemical characteristics of inhaled antibiotics related to tolerability.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2025.08.007]

  • Pérez Menéndez Conde C, Martínez Castro B, Pérez Abánades M, Fernández de Gamarra-Martínez E, Negro-Vega E.

    Generational priorities, motivations, concerns, and expectations of hospital pharmacists in Spain.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2026.01.007]

  • Rodríguez-Tierno S, Fernández-Fradejas J, Vélez-Díaz-Pallarés M, Alonso-Gordoa T, Vivancos-Gallego MJ, Álvarez-Díaz A, Martínez-Barros H.

    Immune checkpoint inhibitors for the treatment of cancer in people living with HIV.

    JOURNAL OF ONCOLOGY PHARMACY PRACTICE . : .

    [doi:10.1177/10781552261430873]

  • Guijarro-Martínez P, Sánchez-Cuervo M, Parro-Martín MÁ, Gómez Bayona E, Luna de Abia A, Chinea Rodríguez A, Herrera Puente P, Hinojo Marín B, Nova Ruiz G, López Jiménez J, Martín-Aragón S, Álvarez-Díaz AM.

    Comprehensive PHARmaceutical care programme in patients undergoing ALLOgeneic haematopoietic stem cell transplantation (PHARALLO): protocol for a prospective interventional study with a historical control group.

    European Journal of Hospital Pharmacy . : .

    [doi:10.1136/ejhpharm-2025-004850]

  • Pérez Menéndez Conde C, Martínez Castro B, Pérez Abánades M, Fernández de Gamarra-Martínez E, Negro-Vega E.

    [Translated article] Generational priorities, motivations, concerns, and expectations of hospital pharmacists in Spain.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2026.03.013]